Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2003
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/30/2003US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal
10/30/2003US20030203941 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203907 Novel pyrazinone derivatives
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203899 Drugs for incontinence
10/30/2003US20030203891 A veterinary medicine for controlling parasites and pests on animals
10/30/2003US20030203877 Such as dipyroxylamine; for treating and preventing chronic tissue damage and diabetic complications (dialysis-related pathologies, proteinuria, impaired glomerular clearance, diabetic nephropathy, and protein crosslinking)
10/30/2003US20030203405 Comprises 4-(4-((acetylamino-ethylcarbamoyl-methyl)-amino)-phenyoxy)butyric acid as building blocks for solid phase synthesis; microarrays
10/30/2003CA2482510A1 Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1357103A1 Reaction method utilizing diaphram type catalyst and apparatus therefor
10/29/2003EP1356816A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355883A2 Novel multidentate sulfur-containing ligands
10/29/2003EP1355879A1 Carboxamides as fungicides in agriculture
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1184375B1 Process for preparing tribromomethylsulfonylpyridine
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1086193B1 Monostable ferroelectric active matrix display
10/29/2003EP0977739B1 Synthesis of intermediates useful in preparing tricyclic compounds
10/29/2003EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003CN1452621A Process for preparing substd. imidazopyridine compound
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1451657A Process for preparing gamma-(p-formolstyryl) pyridine
10/28/2003US6639109 Process for production of thioalkylamine derivatives
10/28/2003US6639079 Forming 3,5-dichloropyridine by two step process without intermediate purification; reacting acrylonitrile with anhydrous chloral to form 2,3,5-trichloropyridine and dechlorinating using zinc metal and acetic acid
10/28/2003US6639073 Ruthenium complex useful as sensitizer, dye-sensitized oxide semiconductor electrode and solar cell using same
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638954 Δ2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
10/28/2003US6638952 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638946 Substituted pyridine or piperidine compounds
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638940 Tetrahydropyridines as pesticides
10/28/2003US6638935 Heteroary1 derivatives and their use as medicaments
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003CA2249786C Difluoro statone analogs
10/28/2003CA2136638C New method of combatting insect eggs and ovicidal compositions
10/28/2003CA2040423C Fluorobenzene derivatives and liquid-crystalline medium
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087066A1 α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087058A1 Novel oxime o-ether compound, production process, and agricultural or horticultural bactericide
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087056A1 Novel oxime o-ether compound, production process, and agricultural or horticultural bactericide
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003087034A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/23/2003WO2003087032A1 Analogous compounds of strobilurines and their use as acaricides and insecticides
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086388A1 Estrogen receptor modulators
10/23/2003WO2003086377A1 Amide derivatives
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002081483A3 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/23/2003WO2002042272A8 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199708 Process for the preparation of cyclic diketones
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199692 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199554 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
10/23/2003US20030199511 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199453 Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs
10/23/2003US20030199046 Processes and intermediates useful in preparing beta3-adrenergic receptor agonists
10/23/2003US20030197183 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes
10/22/2003EP1354586A1 The use of hydroxpyridone-derivatives in wound healing
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 633